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THE IMPACT OF COGNITIVE DEFICITS AND SPASTICITY ON  
DRIVING SIMULATOR PERFORMANCE IN MULTIPLE SCLEROSIS 
 
Thomas D. Marcotte1, Theodore J. Rosenthal2, Jody Corey-Bloom1,  
Erica Roberts1, Sara Lampinen1, and R. Wade Allen2 
1University of California 
San Diego, California, USA 
2Systems Technology, Inc. 
Hawthorne, California, USA 
E-mail: tmarcotte@ucsd.edu 
 
Summary: Multiple sclerosis (MS) is a demyelinating disease that can result in 
numerous sequelae. Although spasticity and cognitive dysfunction are common in 
MS, few studies have examined the impact of both factors on driving abilities in 
persons with physical impairments. The present study assessed driving 
performance in control participants and MS patients with documented spasticity 
using two brief simulations designed to measure lane tracking (under high 
cognitive load) and car following behavior. Seventeen MS patients and 9 controls 
participated in the study. The MS cohort exhibited a broad range of cognitive 
functioning (normal to significant impairment) and disability (Expanded 
Disability Status Scale scores of 3.0 to 7.5). Eight of the MS patients had 
significant spasticity in their right knee based upon the Modified Ashworth 
Spasticity Scale. MS patients had greater difficulty than controls on the 
simulations, particularly on the car following task. MS participants also tended to 
drive at higher speeds than the control participants. Within the MS cohort, 
cognitive dysfunction was most strongly associated with lane tracking 
decrements, whereas the possible relationship between cognitive function and car 
following behavior was eclipsed by lower limb spasticity. Spastic individuals had 
greater difficulty mirroring speed changes in the lead car, and were approximately 
one second slower in responding to its accelerations and decelerations. The 
current simulations provide important data regarding the impact various MS 
sequelae may have on driving performance, and may ultimately lead to clinical 
recommendations regarding specific driving behaviors and their associated risks.  
 
INTRODUCTION 
 
Multiple sclerosis (MS) is a chronic inflammatory, progressive demyelinating disease that causes 
disability in middle-aged adults. The sequelae from MS vary from patient to patient; the most 
common manifestations including spasticity, visual blurring, ataxia, and cognitive impairment. 
Spasticity is an abnormal increase in muscle tone that is typically velocity-dependent (how fast 
the joint is moved through its range), and frequently results in disability.  
 
Such sequelae often affect everyday functioning, including the patient’s ability to safely drive an 
automobile. For example, MS patients were found to have a higher rate of automobile crashes 
than controls (Lings, 2002; Schultheis, Garay, Millis, & Deluca, 2002), and to have greater 
difficulty on a driving simulator (Kotterba et al., 2003). Schultheis et al. (2001) reported that MS 
participants with documented cognitive impairment performed more poorly on measures 
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associated with driving performance, including the Neurocognitive Driving Test (NDT) and the 
Useful Field of View (Ball & Roenker, 1998), a test of visual attention that has been shown to be 
predictive of driving accidents in older adults (Owsley et al., 1998).  
 
In the interest of addressing the potential impact of cognitive impairment on driving, many 
studies have opted to exclude MS participants with greater than minimal physical disability. This 
potentially excludes an important, and large, subgroup of MS patients. 
 
The goal of the present study was to examine the contribution of both physical and cognitive 
sequelae to driving impairment in drivers with documented MS-associated spasticity. To assess 
different components of driving performance, we utilized simulations that measured (1) lane 
tracking under high cognitive workload, and (2) response to lead-car speed changes, emphasizing 
lower limb mobility under limited cognitive load. 
 
METHODS 
 
Participants 
 
Participants consisted of 17 persons with documented multiple sclerosis (MS) and 9 controls. 
The MS participants were enrolled in a clinical trial for the treatment of MS-related spasticity, 
and only pre-treatment, baseline data were used in these analyses. In order to be included in this 
study, all participants had to have routinely driven an automobile in their lifetime, including a 
minimum of 250 miles in the past year. MS participants were included if they had: (1) definite or 
probable MS, (2) complaints of spasticity and at least moderate increase in tone, (3) were 
between the ages of 18 and 65, (4) fluent in English, and (5) on a stable dose of either Baclofen 
or Zanaflex for at least three months. Participants were excluded if they had: (1) significant Axis 
I psychiatric disorder or neurological disease other than MS, (2) recent active substance abuse, 
(3) an unstable medical problem, (4) required benzodiazepines to control spasticity, or (5) used 
sedative or high doses of analgesic medications frequently. Control participants were recruited 
from the community, required to be current drivers, and were excluded if there was a history of 
any CNS disorder that might affect cognition, evidence of a head injury with loss of 
consciousness > 30 minutes, or a history of drug abuse.  
 
The two groups were well matched with respect to age, education, ethnicity and driving history, 
although there were slightly more females in the MS group (Table 1). 
 
Table 1. Demographics of the control and MS participants 
 Control (n = 9) 
MS 
(n = 17) 
 
p 
Age 48.3 (14.0) 49.6 (7.9) .78 
Education (years) 15.3 (2.4) 14.5 (2.1) 39 
Gender (% female) 33% 65% .22 
Ethnicity (% white) 89% 94% .89 
Miles driven in past year 6,345 (3,346) 4,724 (3,573) .27 
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The MS group evidenced a range of disability as assessed by the Kurtzke Expanded Disability 
Status Scale (EDSS). The median score for the group was 6.0 (intermittent or unilateral constant 
assistance to walk about 100 meters; EDDS range =  3.0 to 7.5). On the Ashworth Spasticity 
Scale (Bohannon & Smith, 1987, see below), 8/17 (47%) of the cohort had clinically significant 
spasticity in their right knee, while 9/17 (53%) did not. 
 
Procedures 
 
Neuropsychological testing. MS participants completed a brief neuropsychological test battery 
designed to assess domains frequently affected by multiple sclerosis. The battery assessed Motor 
functioning (Grooved Pegboard Test), Speed of Information Processing (Trailmaking Test Part 
A, WAIS-III Digit Symbol), Attention/Working Memory (Paced Auditory Serial Addition Test), 
Executive Functioning (Trailmaking Test Part B), and Learning and Memory (Hopkins Verbal 
Learning Test). Control subjects completed a subset of these tests (Trailmaking Test, Digit 
Symbol, Hopkins Verbal Learning Test) to ensure that there were no significant, undiagnosed 
disorders. Overall cognitive functioning was estimated using the Global Deficit Score (GDS) 
approach, in which impaired performances on cognitive tests (based upon demographically-
corrected T scores) are weighted more heavily than average and above average performance. 
Test performance in the normal range yields a GDS of 0, whereas severe impairment would be 
assigned a score of 5 (i.e., a higher GDS indicates greater impairment). This approach has been 
shown to be sensitive to cognitive dysfunction for a variety of disorders (Carey et al., 2004).  
 
Spasticity assessment. MS participants were assessed for level of spasticity using the Modified 
Ashworth Spasticity Scale (Bohannon & Smith, 1987), an examiner-administered, independent 
measure of spasticity. Spasticity was rated bilaterally for the elbow, hip and knee. Since the 
focus of this study was performance on the driving simulator, in particular the effect that 
spasticity might have on pedal performance, we used the participant’s right knee as the primary 
joint of interest. 
  
Driving simulation. All participants completed a 15-minute driving simulation. The simulation 
was presented on a Pentium III PC computer using a 17” monitor at 1280 x 1024 resolution, and 
running STISIM Drive version 2.0 software (Systems Technology, Inc., Hawthorne, CA). 
Hardware included a steering wheel, turn signal, and brake/accelerator pedals (Rosenthal, 1999). 
The system provided auditory feedback (e.g., engine noise). Two separate tasks were embedded 
within the one simulation. The first simulation task, lasting approximately 7 minutes, required 
participants to maintain lane position while holding a constant speed (55 mph). Cognitive 
workload, and thus the sensitivity of the measure, was increased by having participants attend to 
divided attention tasks in the corner of the monitor; they were to respond to a triangle in the left 
or right corners of the monitor by pressing the left or right turn signal, respectively, and to a 
picture of a horn in either corner by pressing a button on the console. The scenery consisted of a 
straight, two-lane roadway with mountains and clouds on the horizon. During the simulation 
subjects were not required to negotiate any curves or turns, and there were no traffic, pedestrians, 
or traffic control devices used during the drive. The primary outcome was the standard deviation 
of lateral position (SDLP), a measure of how well participants maintain their lane position. This 
measure has been shown to have good test-retest reliability (Marcotte et al., 2005), and previous 
studies have shown performance on versions of this simulator to be sensitive to illicit substance 
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use (Stein, Allen, Cook, & Karl), sleep apnea (Risser, Ware, & Freeman, 2000), and HIV-
associated cognitive impairment (Marcotte et al., 1999). 
 
The second simulation lasted approximately 8 minutes and required participants to follow a lead 
vehicle at a safe and constant distance. The lead vehicle changed speed following a sinusoidal 
wave with an amplitude of 6 mph. Each change in speed occurred over a period of 1 minute. The 
mean velocity of the lead vehicle was 55 mph. The primary outcomes were the coherence 
(correlation coefficient) between the participant and lead car (a general measure of the 
participants ability to accurately track the speed variations of the lead car), time delay (or the 
reaction time to changes in the lead car’s speed), and modulus (amplitude ratio; the degree to 
which participants under- or over-shoot the distance with the lead car). Details of this simulation 
and outcome measures can be found in the paper presented by Allen et al. (2005) at this 
conference. 
 
Statistical analyses. A number of the driving simulation variables were not normally distributed, 
and thus were transformed. SDLP, modulus, and Time Delay were log transformed, while 
Coherence was transformed using the Box Cox procedure. Raw scores are shown in tables and 
figures to aid interpretation; all statistical analyses utilized the transformed variables. Since the 
sample sizes for this study are small, yielding limited power, we report Cohen’s d, an indicator 
of the effect size of the differences between two groups. Following Cohen’s recommendations 
(1988), effect sizes of .2 were considered “small,” .5 “medium,” and .8 “large.” 
 
RESULTS 
 
The initial analyses involved a comparison of the MS and control participants on each of the 
driving simulator outcomes. There was a large effect size for average speed, with the MS patients 
driving significantly faster on the simulation, and a medium effect size for SDLP. Speed deviation 
did not differ by group. MS participants had greater difficulty than controls in tracking the 
movements of the lead car on the car following task (coherence correlation of .61 vs. .83; large 
effect size), and MS participants were more slow to respond to the changes in the lead car’s speed 
(Time Delay; large effect size). The MS participants were no more likely to over- or under-shoot 
the distance between the lead car. The modulus and time delay findings were similar when two 
participants with a coherence of less than .3 (indicating inconsistent/incorrect performance on the 
task) were removed from the analyses. 
 
Table 2. Simulator performance of the control and MS participants 
 Control  (n = 9) 
MS  
(n = 17) 
Cohen’s  
d 
 
p 
Lane Tracking     
Average Speed 55.2 (7.0) 61.8 (8.5) .87 .06 
Average Speed Deviation 3.3 (2.5) 3.4 (1.8) .05 .86 
SDLP (log) .38 (.07) .42 (.11) .43 .24 
Car Following     
Coherence .83 (.12) .61 (.22) 1.2 .02 
Time Delay (sec) .39 (.28) 1.9 (2.0) 1.1 .04 
Modulus 1.1 (.11) 1.2 (.15) .12 .70 
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We next sought to determine whether cognitive functioning and/or spasticity indicators were 
predictors of simulator performance within the MS group. Analyses included (a) correlational 
analyses using the continuous global deficit score as an indicator of neurocognitive status, and 
(b) clinically significant vs. insignificant spasticity in the right knee (Ashworth ≥ 2) as the 
indicator of task relevant spasticity.    
 
Greater cognitive dysfunction was associated with faster driving speed (r = .51, p = .008), greater 
variability in speed maintenance (r = .39, p = .047), and a larger SDLP (r = .65, p = .005). Neuro-
psychological functioning was not predictive of performance on the car following task: 
coherence (r = -0.30, p = .24), modulus (r = .15, p = .58) or Time Delay  (r = .33, p = .21).  
 
Conversely, as seen in Figure 1, spasticity was significantly associated with a number of car 
following outcomes, but not SDLP. The largest effect size was for coherence (Cohen’s d = 1.0,  
p = .047), followed by the Time Delay (d = .62, p = .25). Small to medium effect sizes were 
found for Modulus (d = .40) and SDLP (d = .36). 
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Figure 1. Performance on the car following task (MS patients only) 
 
DISCUSSION 
 
The current study is one of few to address driving performance in MS drivers with significant  
spasticity. Using two simulator paradigms, MS participants exhibited decreased driving skills 
relative to control participants, particularly with respect to their ability to adjust to changes in the 
speed of a lead car (making adjustments, on average, approximately 1 second slower than 
controls).  
 
Within the MS cohort, cognitive and physical impairments independently contributed to specific 
deficits in driving performance. Cognitively impaired participants had greater difficulty on a 
simulation requiring lane tracking under high cognitive load, suggesting that these individuals may 
have difficulty under complex driving situations. Cognition was not significantly associated with 
poor performance on the car following task, however. Success on this measure, rather, was more 
impacted by lower limb spasticity, with the spastic group having greater trouble in adjusting to 
changes in lead car speed, presumably due to less muscle control in the area of the accelerator 
pedal. In other studies, reduced car following behavior has been associated with alcohol and 
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marijuana administration (Ramaekers, Robbe, & O'Hanlon, 2000) and prescription drug 
administration (Weiler et al., 2000). We suspect that in the present study, an underlying 
relationship between car following and cognitive status was overshadowed by the impact of lower 
limb spasticity.  
 
Interestingly, the MS patients in the current study tended to drive at higher speeds on the simulator, 
which is somewhat concerning considering the delay in responding to lead car accelerations and 
decelerations. 
 
Limitations to the present study include the small sample sizes, and limited simulator evaluations. 
The simulations were intentionally brief in order to be practical for use in clinical trials, but there is 
likely a cost with respect to sensitivity and reliability of the findings. There are also many other 
sequelae associated with MS that may impact driving performance, and these were not addressed 
here. 
 
Nonetheless, the present study does provide new data regarding the impact that various MS 
conditions may have on a person’s ability to safely drive an automobile. Clinicians may want to 
consider discussing the potential driving conditions (e.g., close car following, multi-tasking) that 
may put particular patients at risk for automobile accidents. 
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